AstraZeneca writes to EMA: Fewer thrombosis cases than expected *** BILDplus content *** – Domestic policy

AstraZeneca writes to EMA

Fewer thrombosis cases than expected


AstraZeneca writes to EMA: Fewer thrombosis cases than expected
Photo: DADO RUVIC / REUTERS

This Thursday the European Medicines Commission (EMA) wants to announce how things will go with the AstraZeneca vaccine!

Will vaccination be stopped – or may vaccinations be re-vaccinated? Because: Germany, France, Italy and other EU countries have suspended vaccination with the British-Swedish active ingredient after isolated serious side effects (thrombosis) occurred in those vaccinated.

BILD has an exclusive letter from AstraZeneca to the EU pharmaceutical authority EMA. Read with BILDplus what the vaccine manufacturer says about side effects, especially about thrombosis!

Leave a Comment